Capital Impact Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,925
| Closed | -$353K | – | 9 |
|
|
2024
Q2 | $353K | Sell |
13,925
-837
| -6% | -$21.2K | 0.99% | 49 |
|
|
2024
Q1 | $456K | Sell |
14,762
-6,511
| -31% | -$201K | 0.59% | 71 |
|
|
2023
Q4 | $859K | Hold |
21,273
| – | – | 1.13% | 37 |
|
|
2023
Q3 | $561K | Sell |
21,273
-6,393
| -23% | -$169K | 0.94% | 51 |
|
|
2023
Q2 | $476K | Hold |
27,666
| – | – | 0.52% | 92 |
|
|
2023
Q1 | $459K | Sell |
27,666
-5,003
| -15% | -$83K | 0.56% | 78 |
|
|
2022
Q4 | $249K | Sell |
32,669
-2,711
| -8% | -$20.7K | 0.24% | 168 |
|
|
2022
Q3 | $341K | Buy |
35,380
+5,371
| +18% | +$51.8K | 0.34% | 125 |
|
|
2022
Q2 | $272K | Buy |
+30,009
| New | +$272K | 0.25% | 172 |
|